{"id":"CHEMBL100622","canonicalSmiles":"C[N+](C)(C)CCCCCC[N+](C)(C)C","inchiKey":"VZJFGSRCJCXDSG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXAMETHONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hexamethone","Hexamethonium cation","Hexamethonium ion","Hexathonide"],"crossReferences":{"PubChem":["11111255","11111256","144205589","170465837","90340749","90340750"],"drugbank":["DB08960"],"chEBI":["5700"]},"childChemblIds":["CHEMBL105608","CHEMBL1405927","CHEMBL2106279","CHEMBL332524","CHEMBL3229240","CHEMBL121721","CHEMBL2146097"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1008","canonicalSmiles":"CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1","inchiKey":"UIEATEWHFDRYRU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEPRIDIL","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bepadin","Bepridil","Vascor"],"crossReferences":{"PubChem":["104171114","124879417","124879419","144203640","170465240","26755663","26755664","50110980","90341574"],"Wikipedia":["Bepridil"],"drugbank":["DB01244"],"chEBI":["3061"]},"childChemblIds":["CHEMBL1257078","CHEMBL1200382"],"linkedTargets":{"rows":["ENSG00000075461","ENSG00000157388","ENSG00000142408","ENSG00000157445","ENSG00000100346","ENSG00000165995","ENSG00000151067","ENSG00000166862","ENSG00000148408","ENSG00000198216","ENSG00000167535","ENSG00000105605","ENSG00000006116","ENSG00000007402","ENSG00000081248","ENSG00000102001","ENSG00000151062","ENSG00000006283","ENSG00000130433","ENSG00000141837","ENSG00000075429","ENSG00000108878","ENSG00000182389","ENSG00000196557","ENSG00000153956","ENSG00000067191"],"count":26},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990 and is indicated for cardiovascular disease."}
{"id":"CHEMBL1076544","canonicalSmiles":"O=C(Nc1ccccc1-c1ccc(Cl)cc1)c1cccnc1Cl","inchiKey":"WYEMLYFITZORAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BOSCALID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAS 510 F","Bas 510","Bas-510","Boscalid","Emerald","Endura","Nicobifen"],"crossReferences":{"PubChem":["144214006","26757126","29216431"],"drugbank":["DB12792"],"chEBI":["81822"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1110","canonicalSmiles":"Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O","inchiKey":"JSWZEAMFRNKZNL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALOSETRON","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["A03AE01","Alosetron","Lotronex"],"crossReferences":{"DailyMed":["alosetron%20hydrochloride"],"Wikipedia":["Alosetron"],"drugbank":["DB00969"],"chEBI":["253342"]},"childChemblIds":["CHEMBL1200885"],"linkedTargets":{"rows":["ENSG00000166736"],"count":1},"linkedDiseases":{"rows":["EFO_0010282","EFO_0000555"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for gastrointestinal disease and irritable bowel syndrome and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL113381","canonicalSmiles":"O=S(=O)(Nc1cccc(B(O)O)c1)c1cc(S(=O)(=O)c2ccccc2)cs1","inchiKey":"YZOKHYPIQNIFRQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL113381","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02858"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL116736","canonicalSmiles":"O=CO","inchiKey":"BDAGIHXWWSANSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORMIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E236"],"crossReferences":{"Wikipedia":["Formic_acid"],"drugbank":["DB01942"],"chEBI":["30751"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1194325","canonicalSmiles":"O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1","inchiKey":"ASMXXROZKSBQIH-VITNCHFBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACLIDINIUM","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Aclidinium","Aclidinium cation","Aclidinium ion"],"crossReferences":{"DailyMed":["aclidinium%20bromide"],"drugbank":["DB08897"],"chEBI":["65346"]},"childChemblIds":["CHEMBL551466"],"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0000464","EFO_0006505","MONDO_0004979","EFO_0003768","EFO_0000341"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 5 approved and 2 investigational indications."}
{"id":"CHEMBL119625","canonicalSmiles":"O=C(O)Cn1c(=O)c(=O)[nH]c2cc([N+](=O)[O-])c(-n3ccnc3)cc21","inchiKey":"SPXYHZRWPRQLNS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZONAMPANEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["YM 872 ANHYDROUS","YM-872","YM-872 ANHYDROUS","YM872","YM872 ANHYDROUS","Ym 872","Zonampanel","Zonampanel anhydrous","Zonampanel monohydrate"],"linkedTargets":{"rows":["ENSG00000125675","ENSG00000120251","ENSG00000155511","ENSG00000152578"],"count":4},"linkedDiseases":{"rows":["HP_0002140","EFO_0000712"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1200494","canonicalSmiles":"Cl.N=C(N)NC(=O)Cc1c(Cl)cccc1Cl","inchiKey":"DGFYECXYGUIODH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANFACINE HYDROCHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL862","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Akfen","Estulic","Guanfacine hydrochloride","Intuniv","Tenex"],"synonyms":["BS 100-141","BS-100-141","Guafacine hydrochloride","Guanfacine hcl","Guanfacine hydrochloride","SPD503"],"crossReferences":{"DailyMed":["guanfacine%20hydrochloride"],"PubChem":["11532959","144203710","170465381","50106306","56422899"]},"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","MONDO_0005090","HP_0100543","EFO_0005411","EFO_0000537"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for hypertension and attention deficit hyperactivity disorder."}
{"id":"CHEMBL1200538","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"AKUJBENLRBOFTD-QZIXMDIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAMETHASONE ACETATE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Betamethasone 21-acetate","Betamethasone acetate","NSC-759196"],"crossReferences":{"DailyMed":["betamethasone%20acetate"],"chEBI":["31275"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_1001222","EFO_0000729","EFO_0009451","HP_0001742","HP_0004798","HP_0006536","MONDO_0002280","MONDO_0002406","EFO_0004255","MONDO_0004979","HP_0003419","EFO_0009552","MONDO_0005178","EFO_0005752","EFO_1001434"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and has 10 approved and 3 investigational indications."}
{"id":"CHEMBL1201059","canonicalSmiles":"CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1.Cl","inchiKey":"SARMGXPVOFNNNG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROGUANIDE HYDROCHLORIDE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1377","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Paludrine"],"synonyms":["336-U-50","336U50","Chlorguanide hydrochloride","Chloroguanide hydrochloride","Chloroquanil","Diguanyl","Drinupal","GW AH7673A","GW-AH7673A","GWAH7673A","Guanatol","M-4888","NSC-12977","NSC-26614","Palusil","Proguanil","Proguanil chloride","Proguanil hcl","Proguanil hydrochloride","Proguanili hydrochloridum","RP-3359","SN-12837"],"crossReferences":{"DailyMed":["proguanil%20hydrochloride"],"PubChem":["144204027","170464800","56463664"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for malaria and has 1 investigational indication."}
{"id":"CHEMBL1201119","canonicalSmiles":"N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)[O-].[Na+]","inchiKey":"SBXXSUDPJJJJLC-YDALLXLXSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"LIOTHYRONINE SODIUM","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1544","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cynomel","Cytomel","Liothyronine sodium","Tertroxin","Thybon","Triiodothyronine","Triiodothyronine,evans","Triostat"],"synonyms":["Basoprocin","Cytobin","Ibiothyron","L-triiodothyronine hydrochloride","L-triiodothyronine sodium salt","Liothyronine hydrochloride","Liothyronine sodium","Liothyronine sodium salt","Liotrix (t3)","Lyothyronin","NSC-758175","NSC-80774","Rathyronine hydrochloride, (s)-","Rathyronine sodium, (s)-","T3 (liotrix)","T3 sodium salt","Triiodothyronine sodium salt","Triiodothyronine sodium, levo"],"crossReferences":{"DailyMed":["liothyronine%20sodium"],"PubChem":["144212831","855617"],"Wikipedia":["Liothyronine"],"chEBI":["6484"]},"linkedTargets":{"rows":["ENSG00000126351","ENSG00000151090"],"count":2},"linkedDiseases":{"rows":["EFO_1001055","EFO_0006859","EFO_0003841","MONDO_0005301","EFO_0005207","EFO_1002017","MONDO_0008315","HP_0030680","EFO_0004705"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1956 and has 4 approved and 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201186","drugType":"Small molecule","blackBoxWarning":false,"name":"BISMUTH SUBCITRATE POTASSIUM","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["1001277","Bismuth subcitrate","Bismuth subcitrate potassium"],"crossReferences":{"DailyMed":["bismuth%20subcitrate%20potassium"],"DrugCentral":["4355"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 4 approved and 2 investigational indications."}
{"id":"CHEMBL1201328","canonicalSmiles":"CCC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2","inchiKey":"XZSMZRXAEFNJCU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARPHENAZINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Carfenazine","Carphenazine"],"crossReferences":{"PubChem":["50125832"],"Wikipedia":["Carfenazine"],"drugbank":["DB01038"]},"childChemblIds":["CHEMBL2358147"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201540","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN SUSP ISOPHANE RECOMBINANT HUMAN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Humulin n","Novolin n"],"synonyms":["Insulin susp isophane recombinant human"],"crossReferences":{"DailyMed":["insulin%20susp%20isophane%20recombinant%20human"]},"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","HP_0003124","EFO_0001645","HP_0003074","MONDO_0005147","EFO_1000897","MONDO_0005148","EFO_0000400","EFO_0000537"],"count":9},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 8 investigational indications."}
{"id":"CHEMBL1201624","drugType":"Unknown","blackBoxWarning":false,"name":"BERACTANT","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Survanta"],"synonyms":["A-60386X","Beractant","Surfactant ta"],"crossReferences":{"DailyMed":["beractant"],"DrugCentral":["5108"],"Wikipedia":["Beractant"]},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 3 approved indications."}
{"id":"CHEMBL1213467","canonicalSmiles":"OC[C@H]1ONC[C@@H](O)[C@@H]1O","inchiKey":"KHVCOYGKHDJPBZ-WDCZJNDASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRAHYDROOXAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03862"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL121810","canonicalSmiles":"CCc1ccccc1NC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)O[C@@H]1N2C","inchiKey":"ZOBDWFRKFSPCRB-UNMCSNQZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GANSTIGMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ganstigmine"],"crossReferences":{"drugbank":["DB06525"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230309","canonicalSmiles":"Cc1c[nH]cn1","inchiKey":"XLSZMDLNRCVEIJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230309","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208246","17389237","49731980"],"drugbank":["DB03385"],"chEBI":["40035"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232088","canonicalSmiles":"CCCCCCCCCCCC[N+](C)(C)CC(=O)[O-]","inchiKey":"DVEKCXOJTLDBFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232088","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144211750"],"drugbank":["DB07631"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235112","canonicalSmiles":"O=C(COP(=O)(O)O)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O","inchiKey":"XPYBSIWDXQFNMH-UYFOZJQFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235112","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13863"],"chEBI":["16905"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235818","canonicalSmiles":"Nc1nc2cc3nc(NCc4cccs4)[nH]c3cc2c(=O)[nH]1","inchiKey":"IQKMJWDYMFWZRF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235818","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08514"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236970","canonicalSmiles":"[Zn+2]","inchiKey":"PTFCDOFLOPIGGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZINC ION","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zinc cation","Zinc ion"],"crossReferences":{"drugbank":["DB14532"],"chEBI":["29105"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 24 investigational indications."}
{"id":"CHEMBL1342","canonicalSmiles":"O=C(O)CCCO","inchiKey":"SJZRECIVHVDYJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OXYBATE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[".gamma.-hydroxybutyrate","Gamma hydroxybutyrate","Gamma-hydroxybutyrate","Oxybate","Xyrem"],"crossReferences":{"DailyMed":["calcium%20oxybate","magnesium%20oxybate","potassium%20oxybate","sodium%20oxybate"],"Wikipedia":["Gamma-Hydroxybutyric_acid"],"drugbank":["DB01440"],"chEBI":["30830"]},"childChemblIds":["CHEMBL1200682","CHEMBL4594393","CHEMBL4594395","CHEMBL4594394"],"linkedTargets":{"rows":["ENSG00000136928","ENSG00000204681"],"count":2},"linkedDiseases":{"rows":["MONDO_0021107","EFO_0005203","EFO_0005687","HP_0001337","EFO_0004777","MONDO_0018044","EFO_0004698","EFO_0003843","Orphanet_2131","Orphanet_93961","MONDO_0005180","MONDO_0004975","MONDO_0016158","MONDO_0007079","EFO_0003918","EFO_0003108","EFO_0004540","EFO_0007462"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for narcolepsy-cataplexy syndrome and narcolepsy and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1372","canonicalSmiles":"N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O","inchiKey":"YPZRWBKMTBYPTK-BJDJZHNGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXIGLUTATIONE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Glutathione disulfide","Oxiglutatione"],"crossReferences":{"DailyMed":["glutathione%20disulfide"],"PubChem":["144206973","26754399","29215201"],"Wikipedia":["Glutathione_disulfide"],"drugbank":["DB03310"],"chEBI":["17858"]},"linkedTargets":{"rows":["ENSG00000104687"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000565","MONDO_0008170","MONDO_0007254","EFO_0003060"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 5 investigational indications."}
{"id":"CHEMBL14245","canonicalSmiles":"CCCCO","inchiKey":"LRHPLDYGYMQRHN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTYL ALCOHOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butyl alcohol"],"crossReferences":{"PubChem":["144204597","144207939","17388872","17389645"],"Wikipedia":["N-Butanol"],"drugbank":["DB02145"],"chEBI":["28885"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1479","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"POZRVZJJTULAOH-LHZXLZLDSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DANAZOL","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Danazol","Danocrine"],"synonyms":["Danazol","NSC-270916","WIN 17,757","WIN-17757"],"crossReferences":{"DailyMed":["danazol"],"PubChem":["144205667","144212257","170464884","26757819","49648394"],"TG-GATEs":["127"],"Wikipedia":["Danazol"],"drugbank":["DB01406"],"chEBI":["4315"]},"linkedTargets":{"rows":["ENSG00000082175","ENSG00000169083"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","Orphanet_84","EFO_0007160","MONDO_0019098","EFO_0000545","EFO_0001065","EFO_1001366","MONDO_0011962","Orphanet_1775","EFO_0003014","HP_0001915","MONDO_0018896","EFO_0009321"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for endometriosis and breast fibrocystic disease and has 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1492500","canonicalSmiles":"CN(C)CC/C=C1\\c2ccccc2CSc2ccccc21","inchiKey":"PHTUQLWOUWZIMZ-GZTJUZNOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOTHIEPIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dosulepin","Dothiepin","Dothirpin"],"crossReferences":{"PubChem":["11112454"],"drugbank":["DB09167"],"chEBI":["36803"]},"childChemblIds":["CHEMBL1711280"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_0003761"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for unipolar depression."}
{"id":"CHEMBL1501","canonicalSmiles":"CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C","inchiKey":"WJOHZNCJWYWUJD-IUGZLZTKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLUOCINONIDE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fluocinonide","Fluocinonide emulsified base","Lidex","Lidex-e","Metosyn","Metosyn fapg","Vanos"],"synonyms":["Fluocinolide","Fluocinonide","NSC-101791"],"crossReferences":{"DailyMed":["fluocinonide"],"PubChem":["144203989","170464717","855724"],"Wikipedia":["Fluocinonide"],"drugbank":["DB01047"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000701","EFO_0000676","EFO_0009552","EFO_0000274","EFO_0000305"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and is indicated for skin disease and hemorrhoid and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL170721","canonicalSmiles":"CC(=O)C=O","inchiKey":"AIJULSRZWUXGPQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLGLYOXAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Oxo-Propionaldehyde"],"crossReferences":{"Wikipedia":["Methylglyoxal"],"drugbank":["DB03587"],"chEBI":["17158"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(/C=C\\c3scnc3C)CS[C@H]12)c1csc(N)n1","inchiKey":"KMIPKYQIOVAHOP-YLGJWRNMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFDITOREN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cefditoren"],"crossReferences":{"drugbank":["DB01066"],"chEBI":["59343"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1743263","canonicalSmiles":"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12","inchiKey":"PBUNVLRHZGSROC-VTIMJTGVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROERGOCRYPTINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alpha-Dihydroergocriptine"],"crossReferences":{"PubChem":["144206629"],"drugbank":["DB11274"],"chEBI":["59919"]},"childChemblIds":["CHEMBL3707289"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1747","canonicalSmiles":"NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O","inchiKey":"NLVFBUXFDBBNBW-PBSUHMDJSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOBRAMYCIN","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aktob","Bethkis","Bramitob","Kitabis pak","Nebcin","Nebicin","Nebramycin","Nebris","Obramycin","Tobi","Tobi podhaler","Tobradex","Tobradex St","Tobralex","Tobramycin","Tobravisc","Tobrex","Tymbrineb","Vantobra"],"synonyms":["47663","NSC-180514","Nebcin","Nebramycin factor 6","Nebramycin vi","Tobramycin"],"crossReferences":{"DailyMed":["tobramycin"],"PubChem":["144204177"],"Wikipedia":["Tobramycin","Tobramycin/dexamethasone"],"drugbank":["DB00684"],"chEBI":["28864"]},"childChemblIds":["CHEMBL3764429","CHEMBL1200780","CHEMBL3989564"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 6 approved and 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1761","canonicalSmiles":"Cl.OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1","inchiKey":"ZFSPFXJSEHCTTR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROCYCLIDINE HYDROCHLORIDE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL86715","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arpicolin","Kemadrin","Muscinil"],"synonyms":["NSC-757293","Procyclidine HCl","Procyclidine hcl","Procyclidine hydrochloride"],"crossReferences":{"PubChem":["144204059","170464805","26748224","26748225","50107359","50107360","56424071","856015"],"Wikipedia":["Procyclidine"],"chEBI":["8449"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1955."}
{"id":"CHEMBL1762621","canonicalSmiles":"COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@](C)(CC[C@H]4C(C)(C)C(=O)C(C#N)=C[C@]34C)[C@]1(C)CC2","inchiKey":"WPTTVJLTNAWYAO-KPOXMGGZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BARDOXOLONE METHYL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bardoxolone methyl","Bardoxolone methyl ester","CDDO-METHYL ESTER","CDDO-Me","NSC 713200","NSC-713200","RTA 402","RTA-402","Rta-402"],"crossReferences":{"PubChem":["144206780","532003"],"drugbank":["DB05983"]},"linkedTargets":{"rows":["ENSG00000104365","ENSG00000132170","ENSG00000079999","ENSG00000116044"],"count":4},"linkedDiseases":{"rows":["Orphanet_63","EFO_0002618","MONDO_0005149","EFO_0001361","MONDO_0100096","EFO_0001642","EFO_0000756","EFO_0000401","EFO_0003884","EFO_0001421","EFO_1001496"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL1865135","canonicalSmiles":"COC1CC(=C(c2cccs2)c2cccs2)C[N+](C)(C)C1","inchiKey":"PDYOTUCJOLELJU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIMEPIDIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Timepidium cation","Timepidium ion"],"crossReferences":{"PubChem":["50125748"],"drugbank":["DB13850"]},"childChemblIds":["CHEMBL2107574"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL188442","canonicalSmiles":"O=C(O)/C(=C/c1ccc(Oc2ccccc2Br)cc1)NC(=O)c1ccccc1","inchiKey":"WLPJLQNKCJWAFL-RGEXLXHISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL188442","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01720"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL194126","canonicalSmiles":"CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O","inchiKey":"VEGXETMJINRLTH-BOZYPMBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL194126","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04729"],"chEBI":["27784"]},"childChemblIds":["CHEMBL1087542"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1950554","canonicalSmiles":"Nc1nc(N/N=C/C2CCCCC2)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"XJFMHMFFBSOEPR-DNZQAUTHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BINODENOSON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Corvue"],"synonyms":["Binodenoson","MRE-0470","MRE0470","Wrc0470"],"crossReferences":{"drugbank":["DB04853"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2008544","canonicalSmiles":"CCc1ccc2c(c1)N(CC(C)CN(C)C)c1ccccc1S2","inchiKey":"USKHCLAXJXCWMO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETYMEMAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethotrimeprazine","Ethylisobutrazine","Etymemazine"],"crossReferences":{"drugbank":["DB11517"]},"childChemblIds":["CHEMBL1967567"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2013174","canonicalSmiles":"CC[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2cc(-c3csc(NC(C)C)n3)nc3c(Cl)c(OCCN4CCOCC4)ccc23)CN1C(=O)[C@@H](NC(=O)O[C@@H]1C[C@@H]2C[C@@H]2C1)C(C)(C)C)C(=O)O","inchiKey":"OTXAMWFYPMNDME-FQQWJMKMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VEDROPREVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-9451","Vedroprevir"],"crossReferences":{"drugbank":["DB12037"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2062257","canonicalSmiles":"Brc1c(NC2=NCCN2)ccc2nccnc12.O=C(O)C(O)C(O)C(=O)O","inchiKey":"QZHBYNSSDLTCRG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRIMONIDINE TARTRATE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL844","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alphagan","Alphagan p","Brimonidine tartrate","Brymont","Lumify","Mirvaso","Qoliana"],"synonyms":["AGN 190342-LF","AGN-190342-LF","AGN-190342LF","Brimonidine d-tartrate","Brimonidine tartrate","Bromoxidine tartrate","Cd-07805","OCU-300","OCU300","UK-14304-18","UK-1430418"],"crossReferences":{"DailyMed":["brimonidine%20tartrate"]},"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["MONDO_0001330","EFO_0004190","EFO_1001069","HP_0010783","EFO_1000879","EFO_1000906","MONDO_0008315","HP_0031284","EFO_0000537","Orphanet_791","EFO_0009606","EFO_1000760","EFO_1001022","MONDO_0021698","MONDO_0005301","EFO_0007141","EFO_0000516","EFO_1001893","EFO_0003822"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 6 approved and 7 investigational indications."}
{"id":"CHEMBL2095211","canonicalSmiles":"C[C@H]1CNCCc2ccc(Cl)cc21.Cl","inchiKey":"ITIHHRMYZPNGRC-QRPNPIFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LORCASERIN HYDROCHLORIDE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL360328","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Belviq","Belviq xr"],"synonyms":["APD-356","APD356","Lorcaserin hcl","Lorcaserin hydrochloride","Lorqess"],"crossReferences":{"DailyMed":["lorcaserin%20hydrochloride"],"chEBI":["65350"]},"linkedTargets":{"rows":["ENSG00000147246"],"count":1},"linkedDiseases":{"rows":["EFO_0004319","EFO_0001073"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 2 investigational indications."}
{"id":"CHEMBL2105053","canonicalSmiles":"CCC(=O)C1(c2ccccc2)CCN(CCOCCO)CC1","inchiKey":"FVYYUBRKVVOOAV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DROXYPROPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Droxypropine"],"crossReferences":{"drugbank":["DB13436"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105212","canonicalSmiles":"CCC(C)C(C)C1Nc2cc(Cl)c(S(N)(=O)=O)cc2S(=O)(=O)N1","inchiKey":"KJLLKLRVCJAFRY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEBUTIZIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Betalevo","Devalene","Mebuthiazide","Mebutizid","Mebutizide","Minusten","Neoniagar","Triniagar"],"crossReferences":{"drugbank":["DB13430"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105612","canonicalSmiles":"CCC(Oc1ccccc1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12","inchiKey":"HOCWPKXKMNXINF-XQERAMJGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPICILLIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Baycillin"],"synonyms":["(1-phenoxypropyl)penicillin",".alpha.-phenoxypropylpenicillin","Phenoxypropylpenicillin","Propicillin","Propicillin potassium","Propicillin potassium salt"],"crossReferences":{"PubChem":["144205529"],"drugbank":["DB13660"],"chEBI":["52429"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL2106650","canonicalSmiles":"O=C1NC2CCCCN2C12CCN(CCCN1c3ccccc3CCc3ccc(Cl)cc31)CC2","inchiKey":"PXUIZULXJVRBPC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOSAPRAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mosapramine","Mosapramine hydrochloride"],"crossReferences":{"PubChem":["144206880"],"drugbank":["DB13676"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106968","canonicalSmiles":"Cc1ccc2c(c1)Sc1ccc(C)cc1S2","inchiKey":"AHXDSVSZEZHDLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MESULFEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mesulfen","Mesulphen","Mitigal","Neosulfine","Odylen","Peligal","Sudermo","Thianthol"],"crossReferences":{"drugbank":["DB13356"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107085","canonicalSmiles":"Nc1ncnc2c1nc(Cl)n2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]2[C@H]1O","inchiKey":"CLLFEJLEDNXZNR-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOCLADESINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["8-CL-CAMP","Adenazole","ICN-1256","NSC-284751","NSC-614491","Tocladesine"],"crossReferences":{"drugbank":["DB13046"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107549","canonicalSmiles":"CC(C)(OCc1nn(Cc2ccccc2)c2ccccc12)C(=O)O","inchiKey":"MTHORRSSURHQPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BINDARIT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AF 2838","AF-2838","Bindarit"],"crossReferences":{"PubChem":["174007203"],"drugbank":["DB12739"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108030","drugType":"Antibody","blackBoxWarning":false,"name":"EXBIVIRUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hepex-b"],"synonyms":["Exbivirumab"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108479","drugType":"Enzyme","blackBoxWarning":false,"name":"RANPIRNASE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Onconase"],"synonyms":["P-30","P-30 PROTEIN","Protein p-30","Ranpirnase","Ribonuclease (rana pipiens)"],"description":"Enzyme drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108638","drugType":"Antibody","blackBoxWarning":false,"name":"RAXIBACUMAB","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abthrax"],"synonyms":["Raxibacumab"],"crossReferences":{"DailyMed":["raxibacumab"],"DrugCentral":["4961"]},"description":"Antibody drug with a maximum clinical trial phase of IV that was first approved in 2012 and is indicated for anthrax infection."}
{"id":"CHEMBL2108677","drugType":"Protein","blackBoxWarning":false,"name":"PEGINTERFERON BETA-1A","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Biib017","Plegridy"],"synonyms":["BIIB-017","BIIB017","Peginterferon beta","Peginterferon beta-1a"],"crossReferences":{"DailyMed":["peginterferon%20beta-1a"],"DrugCentral":["5137"]},"linkedTargets":{"rows":["ENSG00000159110","ENSG00000142166"],"count":2},"linkedDiseases":{"rows":["HP_0000083","MONDO_0005301","EFO_0003929"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for multiple sclerosis and has 4 investigational indications."}
{"id":"CHEMBL2108924","drugType":"Unknown","blackBoxWarning":false,"name":"CINNAMON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ae-cinnamon","B1472","Ceylon cinnamon","Ceylon cinnamon bark","Cinnamomi ceylanici cortex","Cinnamomum","Cinnamomum s whole","Cinnamomum verum","Cinnamomum verum bark","Cinnamomum verum inner bark","Cinnamomum verum powder","Cinnamomum verum stem bark","Cinnamomum verum whole","Cinnamomum zeylanicum bark","Cinnamomum zeylanicum bark powder","Cinnamomum zeylanicum inner bark","Cinnamon","Cinnamon (cinnamomum zeylanicum)","Cinnamon bark","Cinnamon ceylon","Cinnamon whole","Cinnamon, ceylon","Cinnamon,ground","FEMA NO. 2289","Spices, cinnamon, ground","True cinnamon bark","Tvak bark","Xi lan rou gui bark"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109095","drugType":"Antibody","blackBoxWarning":false,"name":"ERLIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Erlizumab","RHUMAB CD18","RHUMAB-CD18"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109138","drugType":"Antibody","blackBoxWarning":false,"name":"MOROLIMUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Morolimumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110789","canonicalSmiles":"CO[C@]12C=C[C@@]3(C[C@@H]1C(C)(C)O)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5","inchiKey":"VSKIOMHXEUHYSI-KNLIIKEYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYPRENORPHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyprenorphine"],"crossReferences":{"drugbank":["DB01480"]},"childChemblIds":["CHEMBL2106063"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL21156","canonicalSmiles":"CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1","inchiKey":"VNDWQCSOSCCWIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL21156","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["103905610","174006716"],"drugbank":["DB04716"],"chEBI":["87103"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2134724","canonicalSmiles":"CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2.O.[Br-]","inchiKey":"KEWHKYJURDBRMN-XSAPEOHZSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"IPRATROPIUM BROMIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1621597","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atrovent","Atrovent aerocaps","Atrovent fte","Atrovent hfa","Atrovent udvs","Ipratrop","Ipratrop steripoule","Ipratropium bromide","Respontin","Rinatec","Tropiovent"],"synonyms":["Ipratropium bromide","Ipratropium bromide anhydrous","Ipratropium bromide hydrate","Ipratropium bromide monohydrate","NSC-759613","SCH 1000-BR-MONOHYDRATE","SCH-1000-BR-"],"crossReferences":{"DailyMed":["ipratropium%20bromide"],"PubChem":["56462997"]},"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","EFO_0000464","EFO_0000274","HP_0001742","EFO_0007214","HP_0006536","Orphanet_1764","MONDO_0005180","EFO_0006505","EFO_1002018","MONDO_0004979","EFO_0000341","HP_0025428","HP_0002307","EFO_0003956"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 10 approved and 4 investigational indications."}
{"id":"CHEMBL2146142","canonicalSmiles":"N=C1NCC[C@H]([C@@H]2NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)C[C@@H](N)[C@H](O)CCN)CNC2=O)N1","inchiKey":"HPWIIERXAFODPP-GHBBWTPBSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ENVIOMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enviomycin","Enviomycin sulfate","Tuberactinomycin n"],"crossReferences":{"drugbank":["DB08993"]},"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2325429","canonicalSmiles":"Cc1ccc(C(=O)N(CCCN)[C@@H](c2oc3cc(Cl)ccc3c(=O)c2Cc2ccccc2)C(C)C)cc1","inchiKey":"PGXYIBJJCLWJST-MUUNZHRXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SB-743921","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SB-743921","SB-743921 FREE BASE","Sb 743921","Sb-743921"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2364633","canonicalSmiles":"CON(C)Cc1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O.Cl","inchiKey":"APPRLAGZQKOUFL-FIPJBXKNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SARECYCLINE HYDROCHLORIDE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2364632","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Seysara"],"synonyms":["P-00562","PO-05672","PO05672","Sarecycline hydrochloride","WC-3035","WC3035"],"crossReferences":{"DailyMed":["sarecycline%20hydrochloride"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for infection and acne."}
{"id":"CHEMBL242580","canonicalSmiles":"Cc1cc(C2CCCCC2)n(O)c(=O)c1.NCCO","inchiKey":"MBRHNTMUYWQHMR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CICLOPIROX OLAMINE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1413","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Loprox","Mycoster"],"synonyms":["Batrafen","Brumixol","Ciclochem","Ciclopirox ethanolamine salt (1:1)","Ciclopirox olamine","Dafnegin","HOE 296","HOE-296","Micoxolamina","NSC-336278"],"crossReferences":{"PubChem":["11113028","124882753","144204332","170464708","26747930","460263","56463527"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2443262","canonicalSmiles":"COc1ccsc1CNCC[C@@]1(c2ccccn2)CCOC2(CCCC2)C1","inchiKey":"DMNOVGJWPASQDL-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OLICERIDINE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Olinvyk","Olynvik"],"synonyms":["Oliceridine","TRV-130","TRV130"],"crossReferences":{"drugbank":["DB14881"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for pain and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL251634","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO","inchiKey":"GAKMQHDJQHZUTJ-ULHLPKEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUOCORTOLONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ficoid 2","Ficoid 2-plus","Ultradil","Ultralanum","Ultraproct"],"synonyms":["Fluocortolone","SH 742","SH-742"],"crossReferences":{"Wikipedia":["Fluocortolone"],"drugbank":["DB08971"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for hemorrhoid."}
{"id":"CHEMBL277577","canonicalSmiles":"O=c1[nH]c(=O)n(COCCO)cc1Cc1cccc(OCc2ccccc2)c1","inchiKey":"CSXNPJKDZKLDET-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL277577","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06873"],"chEBI":["39579"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL29609","canonicalSmiles":"Cc1cc(CCCOc2c(C)cc(-c3noc(C(F)(F)F)n3)cc2C)on1","inchiKey":"KQOXLKOJHVFTRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PLECONARIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pleconaril","VP 63843","VP-63843","WIN 63843","WIN-63843"],"crossReferences":{"PubChem":["170466405"],"Wikipedia":["Pleconaril"],"drugbank":["DB05105"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL306226","canonicalSmiles":"c1ccc2[nH]cnc2c1","inchiKey":"HYZJCKYKOHLVJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZIMIDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1H-Benzimidazole","1H-Benzo[D]Imidazole","1H-Benzoimidazole","Benzimidazole","NSC-759"],"crossReferences":{"PubChem":["144209305","144213638","47193726"],"Wikipedia":["Benzimidazole"],"drugbank":["DB02962"],"chEBI":["41275"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3234681","canonicalSmiles":"CC(C)(C)NC(=O)c1nn(-c2ccc(F)cc2F)c2c1[C@H]1CC[C@@H]2C1","inchiKey":"NTPZXHMTJGOMCJ-WDEREUQCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEDALINAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GRC10693","Grc-10693","Tedalinab"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301570","drugType":"Unknown","blackBoxWarning":false,"name":"NECUPARANIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["M-402 FREE ACID","Necuparanib"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3301578","drugType":"Antibody","blackBoxWarning":false,"name":"EMIBETUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C-8H241","Emibetuzumab","LA480","LY-2875358","LY2875358","La-480"],"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["MONDO_0001056","EFO_0003060","EFO_0000311"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL333325","canonicalSmiles":"C[C@@H](c1nc(-c2ccc(C#N)cc2)cs1)[C@@](Cn1cncn1)(OCOP(=O)(O)O)c1ccc(F)cc1F","inchiKey":"SYTNEMZCCLUTNX-NPMXOYFQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSRAVUCONAZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-379224","Bms-379224","E-1224 FREE ACID","E1224 FREE ACID","Fosravuconazole","Ravuconazole methyl phosphate","Ravuconazole methylphosphate","Ravuconazole phosphoester"],"crossReferences":{"drugbank":["DB15204"],"chEBI":["34549"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL333410","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1CCN(CC(O)c2ccccc2)CC1C","inchiKey":"FRPRNNRJTCONEC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL333410","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01570"]},"childChemblIds":["CHEMBL544820"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3348861","canonicalSmiles":"O=C1c2c(O)cc(O)cc2O[C@H](c2cc(O)c(O)c(O)c2)[C@H]1O","inchiKey":"KJXSIXMJHKAJOD-LSDHHAIUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMPELOPSIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ampelopsin","Ampeloptin","Dihydromyricetin","Myriceline spe","Telocapil"],"crossReferences":{"drugbank":["DB15645"],"chEBI":["28429"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545327","drugType":"Small molecule","blackBoxWarning":false,"name":"TTP-607","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ttp-607"],"linkedTargets":{"rows":["ENSG00000087586","ENSG00000178999","ENSG00000105146"],"count":3},"linkedDiseases":{"rows":["EFO_0000574","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL363847","canonicalSmiles":"CN1CCN(CCn2cnc3c(NC4CCCCC4)nc(C#N)nc32)CC1","inchiKey":"OGODDSLNRULSMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL363847","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07965"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3673452","canonicalSmiles":"COc1ccc(COc2ccc(Cn3c(N)nc4cc(-c5cnn(C)c5)cnc43)cc2OC)cc1","inchiKey":"HVRWZFQFSQUILC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GZ-389988","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GZ-389988","GZ389988","Gz-389988","Gz389988"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707397","drugType":"Small molecule","blackBoxWarning":false,"name":"MR-1817","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mr-1817"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL371315","canonicalSmiles":"NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O","inchiKey":"JJGBXTYGTKWGAT-YUMQZZPRSA-N","drugType":"Protein","blackBoxWarning":false,"name":"Gly-Pro-Glu","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gly-Pro-Glu"],"crossReferences":{"drugbank":["DB05633"]},"childChemblIds":["CHEMBL4449611"],"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL376180","canonicalSmiles":"Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1","inchiKey":"TVZGACDUOSZQKY-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOPTERIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Aminopteroic acid","4-amino-pga","4-aminofolic acid","Aminopterin","Aminopteroylglutamic acid","Aminotrexate","Methotrexate related compound b","NSC-739"],"crossReferences":{"PubChem":["144203620","144210944"],"drugbank":["DB08878"],"chEBI":["22526"]},"childChemblIds":["CHEMBL2104643"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL382301","canonicalSmiles":"CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1","inchiKey":"VWXRQYYUEIYXCZ-OBIMUBPZSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ATOSIBAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tractocile"],"synonyms":["Antocile","Antocin","Antocin ii","Atosiban","CAP-449","CAP-476","CAP-581","F-314","ORF 22164","ORF-22164","RW-22164","RWJ 22164","RWJ-22164","Tractocil"],"crossReferences":{"PubChem":["144207023","29217473"],"drugbank":["DB09059"]},"linkedTargets":{"rows":["ENSG00000180914"],"count":1},"linkedDiseases":{"rows":["EFO_0003917"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL3833406","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC.COc1ccc2c3c1OC1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314","inchiKey":"IAWXESBTFLIKNX-MMWHECRDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAPAVERETUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3833334"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for pain."}
{"id":"CHEMBL391737","canonicalSmiles":"C[C@@H](C(=O)N1CCOCC1)N1CC[C@H](NS(=O)(=O)CCc2ccc(Cl)s2)C1=O","inchiKey":"IAUZEBLXCOCAFL-JSGCOSHPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL391737","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07277"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989547","canonicalSmiles":"Cc1ccc(Oc2ccccc2-c2csc(N=C3NCCCN3)n2)c(C)c1","inchiKey":"TYBHXIFFPVFXQW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABAFUNGIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abafungin","BAY W 6341 ","BAY-W-6341","BAY-W-6341-"],"crossReferences":{"drugbank":["DB06395"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989603","canonicalSmiles":"CCCCCCCCCCCCSCC(COP(=O)(O)OC[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)C[C@@H]1N=[N+]=[N-])OCCCCCCCCCC","inchiKey":"IBHARWXWOCPXCR-WELGVCPWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOZIVUDINE TIDOXIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BM 21.1290","BM-21.1290","BM-211290","Fozivudine tidoxil","HDP 990002","HDP-990002"],"crossReferences":{"drugbank":["DB12423"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989912","canonicalSmiles":"Cl.O=C1CC[C@H](N2Cc3c(OCc4ccc(CN5CCOCC5)cc4)cccc3C2=O)C(=O)N1","inchiKey":"VVHQVXXPZDALDV-BOXHHOBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBERDOMIDE HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL3989927","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CC-220","Cc-220 hydrochloride","Iberdomide hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3989941","canonicalSmiles":"Cn1c(CCCCCCC(=O)NO)nc2cc(N(CCCl)CCCl)ccc21","inchiKey":"GISXTRIGVCKQBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TINOSTAMUSTINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EDO-S 101","EDO-S-101","EDO-S101","Tinostamustine"],"crossReferences":{"drugbank":["DB15147"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4080228","canonicalSmiles":"COc1cc(C)[nH]c(=O)c1CN1CCc2c(Cl)cc([C@H](OC)C3COC3)c(Cl)c2C1=O","inchiKey":"RXCVUHMIWHRLDF-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-06821497","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06821497","Pf-06821497"],"crossReferences":{"drugbank":["DB14799"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL415","canonicalSmiles":"CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21","inchiKey":"GDLIGKIOYRNHDA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLOMIPRAMINE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["3-chloro-iminodibenzyl","Anafranil","Anapramine","Chlorimipramine","Clomicalm","Clomipramine","NSC-169865"],"crossReferences":{"DailyMed":["clomipramine%20hydrochloride"],"PubChem":["104171137","11110978","11110979","11113368","124879726","144203668","170464702","26751616","50100206","50104278","90340575"],"TG-GATEs":["121"],"Wikipedia":["Clomipramine"],"drugbank":["DB01242"],"chEBI":["47780"]},"childChemblIds":["CHEMBL1200710"],"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002050","HP_0000726","EFO_0003761","EFO_0004242","EFO_0005230"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 3 approved and 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL417675","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)NCCO","inchiKey":"HXYVTAGFYLMHSO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALMIDROL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AM 3112","FSD-201","Impulsin","Levagen","Loramine p 256","N(2-hydroxyethyl) palmitide","N(2-hydroxyethyl)palmitide","N-(2-hydroxyethyl)-palmitide","NSC-23320","Palmdrol prodes","Palmidrol","Palmitamide mea","Palmitic acid monoethanolamide","Palmitic monoethanolamide","Palmitoyl ethanolamide","Palmitoylethanolamide"],"crossReferences":{"PubChem":["11113754","144203773","170466102","26751936","50104611","56463464","85231178","90341052"],"Wikipedia":["Palmitoylethanolamide"],"drugbank":["DB14043"],"chEBI":["71464"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL419499","canonicalSmiles":"O=C(NCC(=O)N1[C@H](C(=O)O)CC[C@@H]1c1ccccc1)[C@@H](S)Cc1ccccc1","inchiKey":"ZWDQTNWLXALTOV-QYZOEREBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL419499","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02669"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL429023","canonicalSmiles":"C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1","inchiKey":"JUVIOZPCNVVQFO-HBGVWJBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROTENONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["104171353","11113277","124883112","144204370","144209102","144211012","170466816","26753651","26753652","50107017","50107018","50107019","85231344","87142","90340839"],"Wikipedia":["Rotenone"],"drugbank":["DB11457"],"chEBI":["28201"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297351","canonicalSmiles":"C#CCOc1ccc2c(c1)c(-c1ccc(C(C)C)cc1)nc(=O)n2Cc1ccc2nc(Br)cnc2c1","inchiKey":"ALANRBCCCQEPFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATX-914","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AXT914","Atx-914","Axt914"],"crossReferences":{"drugbank":["DB12673"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4298126","drugType":"Unknown","blackBoxWarning":false,"name":"VON WILLEBRAND FACTOR HUMAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Human von willebrand factor","Von willebrand factor","Von willebrand factor (human)","Von willebrand factor human","Von willebrand factor, human","Von willebrand's factor"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hemorrhage and has 3 investigational indications."}
{"id":"CHEMBL4298211","drugType":"Protein","blackBoxWarning":true,"name":"PEGCETACOPLAN","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Empaveli"],"synonyms":["APL-2","Pegcetacoplan"],"linkedTargets":{"rows":["ENSG00000125730"],"count":1},"linkedDiseases":{"rows":["Orphanet_93571","EFO_0001365","MONDO_0004976","Orphanet_183589","Orphanet_447"],"count":5},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for paroxysmal nocturnal hemoglobinuria and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4299940","canonicalSmiles":"O=C(c1ccc(NS(=O)(=O)c2cccc3cccnc23)cc1)N1CCN(CC2CC2)CC1","inchiKey":"XAYGBKHKBBXDAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MITAPIVAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AG-348","Ag-348","Mitapivat","Pkr-in-1"],"childChemblIds":["CHEMBL4297223"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4301914","canonicalSmiles":"CC(=O)OP(=O)(O)N(C[C@H]1CN(c2cc(F)c(N3C=CC(=O)CC3)c(F)c2F)C(=O)O1)c1ccon1","inchiKey":"YCRAGJLWFBGKFE-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CONTEZOLID ACEFOSAMIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3989966"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL445699","canonicalSmiles":"CCC[C@@]1(CCc2ccccc2)CC(O)=C([14C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1","inchiKey":"SUJUHGSWHZTSEU-MWQIXQBFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL445699","maximumClinicalTrialPhase":0,"parentId":"CHEMBL222559","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15108"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594452","canonicalSmiles":"CCCCCCCCC=CCCCCCCC(O)C(=O)O","inchiKey":"JBSOOFITVPOOSY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-HYDROXYOLEIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-hydroxyoleic acid","2-ohoa","Idroxioleic acid","Minerval","NFX-88","NFX88","SML-0256","SML0256"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594475","drugType":"Protein","blackBoxWarning":false,"name":"GLUCAGON-LIKE PEPTIDE 1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glp-1","Glucagon-like peptide 1"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594510","drugType":"Unknown","blackBoxWarning":false,"name":"VRC07-523LS","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VRC07-523LS","VRC07523LS","Vrc07-523ls"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4650276","canonicalSmiles":"CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(OC[C@@H](O)CO)cc1","inchiKey":"KRBMOYIWQCZVHA-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SHR3680","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SHR3680","Shr3680"],"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0001421","EFO_0000196","MONDO_0008315"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4650302","canonicalSmiles":"O=C([O-])CC(O)(CC(=O)O)C(=O)O.O=C([O-])CC(O)(CC(=O)O)C(=O)O.O=C([O-])CC(O)(CC(=O)[O-])C(=O)O.[K+].[K+].[Mg+2]","inchiKey":"YARCYODLIRKFGQ-UHFFFAOYSA-J","drugType":"Small molecule","blackBoxWarning":false,"name":"MPC-5971","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MPC-5971","Mpc-5971"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650989","canonicalSmiles":"C[C@@H](N)COc1ccc(-c2cnc3ccc(N[C@H](C)c4cccc(F)c4)nn23)cc1","inchiKey":"HEVHTYMYEMEBPX-HZPDHXFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALETRECTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DS-6051","Taletrectinib"],"childChemblIds":["CHEMBL4650361"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL47386","canonicalSmiles":"Oc1cc(O)c2c(c1)O[C@H](c1cc(O)c(O)c(O)c1)[C@H](O)C2","inchiKey":"XMOCLSLCDHWDHP-IUODEOHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPIGALLOCATECHIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-Epigallocatechin","Epigallocatechin"],"crossReferences":{"PubChem":["515468"],"Wikipedia":["Gallocatechol"],"drugbank":["DB03823"],"chEBI":["42255"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL480558","canonicalSmiles":"CCC(CC)[C@@H](CO)NS(=O)(=O)c1ccc(Cl)s1","inchiKey":"PYZFRRVBPNGCBX-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSI-136","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsi-136"],"crossReferences":{"drugbank":["DB12819"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL482811","canonicalSmiles":"CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@@H]1CCCC[C@H]1N1CCCC1.CS(=O)(=O)O","inchiKey":"OJPHNZCUXUUVKU-JAXOOIEVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"U-50488 METHANE SULFONATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL441765","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NCG-C00093883-01","U-50488 methane sulfonate","U-50488H"],"crossReferences":{"PubChem":["11112023","11532953","56422173"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL483254","canonicalSmiles":"Cc1[nH]c2ccccc2c1CCNCc1ccc(/C=C/C(=O)NO)cc1","inchiKey":"FPOHNWQLNRZRFC-ZHACJKMWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PANOBINOSTAT","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Farydak"],"synonyms":["LBH-589","LBH589","Panobinostat","Panobinostat hydrate"],"crossReferences":{"DailyMed":["panobinostat%20lactate"],"drugbank":["DB06603"],"chEBI":["85990"]},"childChemblIds":["CHEMBL3545368"],"linkedTargets":{"rows":["ENSG00000108840","ENSG00000094631","ENSG00000061273","ENSG00000163517","ENSG00000068024","ENSG00000116478","ENSG00000147099","ENSG00000100429","ENSG00000171720","ENSG00000048052","ENSG00000196591"],"count":11},"linkedDiseases":{"rows":["MONDO_0009348","MONDO_0044903","EFO_0004708","Orphanet_232","MONDO_0100342","EFO_1001901","EFO_0000756","EFO_0000681","EFO_0002913","MONDO_0007254","EFO_1000657","EFO_1001469","MONDO_0021063","EFO_0005952","EFO_0004252","EFO_1001951","EFO_0000565","EFO_0002430","MONDO_0001056","EFO_0000339","MONDO_0002898","MONDO_0008903","EFO_0000182","EFO_0000673","EFO_0000326","EFO_0000183","EFO_0002617","EFO_0000198","MONDO_0013730","EFO_0000616","EFO_0009441","EFO_1001779","EFO_0002618","EFO_0000220","EFO_0000349","EFO_0000403","EFO_0000222","EFO_1001968","MONDO_0044881","EFO_0002429","MONDO_0008315","EFO_0003060","EFO_0000311","EFO_0006738","EFO_1000026","MONDO_0002691","EFO_0002892","EFO_0006475","EFO_0000764","EFO_0000574","EFO_0001378","EFO_0000519"],"count":52},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 3 approved and 48 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL506981","canonicalSmiles":"COc1cccc(OC)c1-c1cc(C(=O)NC2(C(=O)O)C3CC4CC(C3)CC2C4)nn1-c1ccnc2cc(Cl)ccc12","inchiKey":"DYLJVOXRWLXDIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REMINERTANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Meclinertant","Reminertant","SR-48692","Sr48692"],"crossReferences":{"PubChem":["124950704"],"drugbank":["DB06455"]},"linkedTargets":{"rows":["ENSG00000101188"],"count":1},"linkedDiseases":{"rows":["EFO_0000702"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL520400","canonicalSmiles":"CN1CCC(N(Cc2ccccc2)c2ccccc2)CC1","inchiKey":"VZSXTYKGYWISGQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAMIPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bamipine","Piperamine"],"crossReferences":{"PubChem":["170466303"],"Wikipedia":["Bamipine"],"drugbank":["DB13489"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL522157","canonicalSmiles":"O=C(N/N=C/c1cc(Br)c(O)c(Br)c1O)c1cccc(Br)c1","inchiKey":"VOWXAXNVAGLOGM-NGYBGAFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL522157","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07044"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL527018","canonicalSmiles":"CC#CCOc1ccc(S(=O)(=O)N[C@H](Cc2c[nH]c3ccc(C)cc23)C(=O)O)cc1","inchiKey":"SFVPXERGVLDWIS-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL527018","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07233"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL54714","canonicalSmiles":"O=P(O)(O)C(Nc1ccc(Cl)cn1)P(=O)(O)O","inchiKey":"BNMYZGAZFGNKTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL54714","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03649"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL55264","canonicalSmiles":"CCCCCCC(O)(P(=O)(O)O)P(=O)(O)O","inchiKey":"IJEGNOYPWRBKAE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL55264","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06830"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL561132","canonicalSmiles":"CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1","inchiKey":"JTCAGRAKUAAYDY-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-7246","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-7246"],"childChemblIds":["CHEMBL2093879"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL607400","canonicalSmiles":"CCC[C@@H]1CC(=O)N([C@@H](CC)C(N)=O)C1","inchiKey":"MSYKRHVOOPPJKU-BDAKNGLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRIVARACETAM","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Briviact"],"synonyms":["Brivaracetam","UCB 34714","UCB-34714"],"crossReferences":{"DailyMed":["brivaracetam"],"Wikipedia":["Brivaracetam"],"drugbank":["DB05541"]},"linkedTargets":{"rows":["ENSG00000159164"],"count":1},"linkedDiseases":{"rows":["Orphanet_308","EFO_0000474","MONDO_0041052","EFO_1001919","HP_0001250","EFO_0003833"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for seizure and epilepsy and has 3 investigational indications."}
{"id":"CHEMBL7568","canonicalSmiles":"CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12","inchiKey":"GPKJTRJOBQGKQK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINACRINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atabrine","GNF-Pf-5448","Mepacrine","Quinacrine"],"crossReferences":{"PubChem":["124881289","50111199","90341425"],"Wikipedia":["Mepacrine"],"drugbank":["DB01103"],"chEBI":["8711"]},"childChemblIds":["CHEMBL2105615","CHEMBL556980","CHEMBL554190","CHEMBL546257"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL77305","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c([N+](=O)[O-])cccc3nc2-1","inchiKey":"VHXNKPBCCMUMSW-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUBITECAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9-nc","9-nitro-20(s)-camptothecin","9-nitro-20-(s)-camptothecin","9-nitrocamptothecin","RFS 2000","RFS-2000","RFS2000","Rubitecan"],"crossReferences":{"PubChem":["144206150","50113013"],"Wikipedia":["Rubitecan"],"drugbank":["DB06159"],"chEBI":["90225"]},"linkedTargets":{"rows":["ENSG00000198900"],"count":1},"linkedDiseases":{"rows":["MONDO_0001187","EFO_0000616","EFO_0002618","MONDO_0004192","EFO_0000389","MONDO_0008170","MONDO_0011962","MONDO_0008903","MONDO_0007254","MONDO_0002087","MONDO_0020654","EFO_1000158","EFO_1001951"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL87045","canonicalSmiles":"c1ccc(C2(c3ccccc3)CC2C2=NCCN2)cc1","inchiKey":"IPOBOOXFSRWSHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIFENLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cibenzoline","Cifenline","RO 22-7796","RO-22-7796"],"crossReferences":{"PubChem":["26755692","90341191"],"Wikipedia":["Cibenzoline"],"drugbank":["DB13358"]},"childChemblIds":["CHEMBL2106074","CHEMBL3189111"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
